The safety profile of GH replacement therapy in adults

Clinical Endocrinology

Volumn 46, Issue 4, 1997, Pages 473-481

  Chipman, J J ^a   Attanasio, A F ^a   Birkett, M A ^a   Bates, P C ^a   Webb, S ^b   Lamberts, S W J ^c  

^a ELI LILLY AND COMPANY   (United States)

^b HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^c ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; GLYCOSYLATED HEMOGLOBIN; GROWTH HORMONE; HUMAN GROWTH HORMONE; INSULIN; PLACEBO; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ADULT; ARTHRALGIA; ARTICLE; CHILD; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG SAFETY; FEMALE; GLUCOSE TOLERANCE; GROWTH HORMONE DEFICIENCY; HORMONE SUBSTITUTION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MYALGIA; ONSET AGE; PARESTHESIA; PATHOGENESIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0031007701     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.1997.1660984.x     Document Type: Article

References (13)

1. Arslanian, S.A., Becker, D.J., Lee, P.A., Drash, A.L. & Foley, T.P. (1985) Growth hormone therapy and tumor recurrence. American Journal of Diseases of Children, 139, 347-350.
2. Attanasio, A.F., Lamberts, S.W.J., Matranga, A.M.C., Birkett, M.A., Bates, P.C., Valk, N.K., Hilsted, J., Bengtsson, B-A. & Strasburger, C.J. (1997) Adult growth hormone deficient patients demonstrate heterogeneity between childhood onset and adult onset prior to and during human growth hormone treatment. Journal of Clinical Endocrinology and Metabolism, 82, 82-88.
3. Blum, W.F. & Breier, B.H. (1994) Radioimmunoassays for IGFs and IGFBPs. Growth Regulation, 4(suppl 1), 11-19.
4. Clayton, P.E., Price, D.A., Shalet, S.M. & Gattemaneni, H.R. (1988) Craniopharyngioma recurrence and growth hormone therapy. Lancet, i, 642.
5. Cohn, L., Feller, A.G., Draper, M.W., Rudman, I.W. & Rudman, D. (1993) Carpel tunnel syndrome and gynecomastia during growth hormone treatment of elderly men with low circulating IGF-I concentrations Clinical Endocrinology, 39, 387-397.
6. Holmes, S.J. & Shalet, S.M. (1995) Which adults develop side-effects of growth hormone replacement? Clinical Endocrinology, 43, 143-149.
7. Kohler, E.A., Stradel, B.V. & Malozowski, S.N. (1995) Papilledema in 13 renal patients treated with GH for impaired growth. Abstracts of The American Pediatric Society and The Society for Pediatric Research, May 7-11, 364A.
8. Lamberts, S.W.J., Valk, N.K. & Binnerts, A. (1992) The use of growth hormone in adults: a changing scene. Clinical Endocrinology, 37, 111-115.
9. Malozowski, S.N., Tanner, L.A., Wysowski, D. & Fleming, G.A. (1993) Growth hormone, insulin-like growth factor-I, and benign intracranial hypertension. New England Journal of Medicine, 329, 665-666.
10. Mårdh, G., Lundin, K., Gorg, G., Jonsson, B. & Lindeberg, A. (1994) Growth hormone replacement therapy in adult hypopituitary patients with growth hormone deficiency: combined data from 12 European placebo-controlled clinical trials. Endocrinology and Metabolism, 1(suppl A), 43-49.
11. Ogilvy-Stuart, A.L., Ryder, W.D.J., Gattemaneni, H.R., Clayton, P.E. & Shalet, S.M. (1992) Growth hormone and tumour recurrence. British Medical Journal, 304, 1601-1605.
12. Rosén, T., Johansson, G., Johansson, J-O & Bengtsson, B-Å. (1995) Consequences of growth hormone deficiency in adults and the benefits and risks of recombinant human growth hormone treatment. Hormone Research, 43, 93-99.
13. Toogood, A.A., O'Neill, P.A. & Shalet, S.M. (1996) Beyond the somatopause: growth hormone deficiency in adults over the age of 60 years. Journal of Clinical Endocrinology and Metabolism, 81, 460-465.